A Mobile Application to Assist Alzheimer’s Caregivers During COVID-19 Pandemic: Development and Evaluation

Author:

Amiri Parastoo1ORCID,Gholipour Maryam1ORCID,Hajesmaeel-Gohari Sadrieh2ORCID,Bahaadinbeigy Kambiz3ORCID

Affiliation:

1. Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran

2. Medical Informatics Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

3. Digital Health Team, The Australian College of Rural and Remote Medicine, Brisbane, QLD, Australia

Abstract

Introduction: Access to healthcare services for patients with Alzheimer’s disease (AD) was limited during the COVID-19 pandemic. A mobile application (app) can help overcome this limitation for patients and caregivers. Our study aims to develop and evaluate an app to help caregivers of patients with AD during COVID-19. Methods: The study was performed in three steps. First, a questionnaire of features required for the app design was prepared based on the interviews with caregivers of AD patients and neurologists. Then, questionnaire was provided to neurologists, medical informatics, and health information management specialists to identify the final features. Second, the app was designed using the information obtained from the previous phase. Third, the quality of the app and the level of user satisfaction were evaluated using the mobile app rating scale (MARS) and the questionnaire for user interface satisfaction (QUIS), respectively. Results: The number of 41 data elements in four groups (patient’s profile, COVID-19 management and control, AD management and control, and program functions) were identified for designing the app. The quality evaluation of the app based on MARS and user satisfaction evaluation based on QUIS showed the app was good. Conclusion: This is the first study that focused on developing and evaluating a mobile app for assisting Alzheimer’s caregivers during the COVID-19 pandemic. As the app was designed based on users’ needs and covered both information about AD and COVID-19, it can help caregivers perform their tasks more efficiently.

Publisher

Maad Rayan Publishing Company

Subject

Health Professions (miscellaneous),General Nursing,Medicine (miscellaneous)

Reference35 articles.

1. Food discoveries for brain fitness;Bliss RM;Agric Res,2010

2. Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: A 26-week, multicenter, open-label study

3. The Economic Burden of Alzheimer's Disease Care

4. World Health Organization (WHO). Dementia. United States: WHO; 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia. Accessed December 20, 2022.

5. Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3